Chromatographic and electrophoretic assessment of Filgrastim biosimilars in pharmaceutical formulations.
暂无分享,去创建一个
[1] G. Laible,et al. Coupled solid phase extraction and microparticle-based stability and purity-indicating immunosensor for the determination of recombinant human myelin basic protein in transgenic milk. , 2013, Talanta.
[2] K. Ganzler,et al. Analytical aspects of biosimilarity issues of protein drugs. , 2012, Journal of pharmaceutical and biomedical analysis.
[3] G. Laible,et al. CZE with On-line Micellar Sample Stacking for Determination of Protein Concentration of Biopharmaceuticals , 2011 .
[4] F. Sörgel,et al. Physicochemical and Biologic Comparability of a Biosimilar Granulocyte Colony-Stimulating Factor with its Reference Product , 2010, BioDrugs.
[5] A. Škrlin,et al. Correlation of liquid chromatographic and biological assay for potency assessment of filgrastim and related impurities. , 2010, Journal of pharmaceutical and biomedical analysis.
[6] A. Škrlin,et al. Comparison of the physicochemical properties of a biosimilar filgrastim with those of reference filgrastim. , 2010, Biologicals : journal of the International Association of Biological Standardization.
[7] G. Laible,et al. Probing the interaction between recombinant human myelin basic protein and caseins using surface plasmon resonance and diffusing wave spectroscopy , 2009, Journal of molecular recognition : JMR.
[8] G. Laible,et al. On-line casein micelle disruption for downstream purification of recombinant human myelin basic protein produced in the milk of transgenic cows. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[9] M. Al-Ghobashy,et al. Factors Affecting the Performance of Capillary Isoelectric Focusing in Dynamically Coated Capillaries Using Polyethylene Oxide Polymer , 2008 .
[10] M. Iwakura,et al. A Systematic and Comprehensive Combinatorial Approach to Simultaneously Improve the Activity, Reaction Specificity, and Thermal Stability of p-Hydroxybenzoate Hydroxylase* , 2007, Journal of Biological Chemistry.
[11] S. Dalmora,et al. Validation of an RP‐LC Method and Assessment of rhG‐CSF in Pharmaceutical Formulations by Liquid Chromatography and Biological Assay , 2006 .
[12] G. Luo,et al. Characterization of recombinant human granulocyte colony stimulating factor (rHuG-CSF) by capillary zone electrophoresis, capillary isoelectric focusing electrophoresis and electrospray ionization mass spectrometry. , 2004, Journal of pharmaceutical and biomedical analysis.
[13] W. Stites,et al. Comparing the effect on protein stability of methionine oxidation versus mutagenesis: steps toward engineering oxidative resistance in proteins. , 2001, Protein engineering.
[14] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[15] D. Niederwieser,et al. The challenge of biosimilars. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] Daniel I. C. Wang,et al. Effects of Excipients on the Hydrogen Peroxide-Induced Oxidation of Methionine Residues in Granulocyte Colony-Stimulating Factor , 2004, Pharmaceutical Research.
[17] L. Sharaf,et al. Filgrastim use: evaluation in cancer and critically ill non- cancer patients , 2003 .
[18] T. Boone,et al. Characterization, formulation, and stability of Neupogen (Filgrastim), a recombinant human granulocyte-colony stimulating factor. , 1996, Pharmaceutical biotechnology.
[19] T. Pritchett. Capillary isoelectric focusing of proteins , 1996, Electrophoresis.